Ridpath, John R. Nakamura, Jun
Published in
Genes and Environment
BackgroundDevelopment of chemotherapeutic/preventive drugs that selectively kill cancer - the Holy Grail of cancer research - is a major challenge. A particular difficulty arises when chemotherapeutics and radiation are found to be rather ineffective against quiescent cancer cells in solid tumors. In the limited oxygen condition within a solid tumo...
Muffarrej, Duaa Khattab, Eman Najjar, Rula
Published in
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Tuysuz, Gulen Guler, Elif Ozel, Deniz Kupesiz, Alphan
Published in
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for bone marrow failure (BMF) in patients with Fanconi anemia (FA). We retrospectively analyzed the records of patients with FA who underwent HSCT with a radiation-free, reduced-intensity conditioning regimen (fludarabine, cyclophosphamide, and antithymocyte globulin) alo...
Chatla, Srinivas Du, Wei Wilson, Andrew F Meetei, Amom Ruhikanta Pang, Qishen
Published in
Stem cell research
Members of the Fanconi anemia (FA) protein family are involved in multiple cellular processes including response to DNA damage and oxidative stress. Here we show that a major FA protein, Fancd2, plays a role in mitochondrial biosynthesis through regulation of mitochondrial translation. Fancd2 interacts with Atad3 and Tufm, which are among the most ...
Fiesco-Roa, Moisés O Giri, Neelam McReynolds, Lisa J Best, Ana F Alter, Blanche P
Published in
Blood reviews
Fanconi anemia (FA) is a genomic instability syndrome with predisposition to congenital abnormalities, bone marrow failure, and cancer. Classical and most frequent congenital abnormalities include all those seen in VACTERL-H association and those described under the PHENOS acronym. Pathogenic variants in at least 22 genes are associated with FA, wh...
Rageul, Julie Weinheimer, Alexandra S Park, Jennifer J Kim, Hyungjin
Published in
DNA repair
Faithful duplication of the genome is critical for the survival of an organism and prevention of malignant transformation. Accurate replication of a large amount of genetic information in a timely manner is one of the most challenging cellular processes and is often perturbed by intrinsic and extrinsic barriers to DNA replication fork progression, ...
Mori, Minako
Kyoto University (京都大学) / 0048 / 新制・課程博士 / 博士(医学) / 甲第22002号 / 医博第4516号 / 新制||医||1038(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 滝田 順子, 教授 松田 文彦, 教授 山田 亮 / 学位規則第4条第1項該当
Esteban-Medina, Marina Peña-Chilet, María Loucera, Carlos Dopazo, Joaquín
Published in
BMC Bioinformatics
BackgroundIn spite of the abundance of genomic data, predictive models that describe phenotypes as a function of gene expression or mutations are difficult to obtain because they are affected by the curse of dimensionality, given the disbalance between samples and candidate genes. And this is especially dramatic in scenarios in which the availabili...
Yang, Qiao Xie, Hui Zhong, Yixinhe Li, Dongbo Ke, Xianfu Ying, Huazhong Yu, Bing Zhang, Tingting
Published in
Biochemical and biophysical research communications
Fanconi anemia (FA) is a genetic disorder characterized by congenital malfunction, bone marrow failure and hypersensitivity to DNA damage. FANCD2 protein play the central role in FA pathway. To study the in vivo role of FANCD2, we generated and characterized a new Fancd2 knockout mouse strain with 7bp deletion in Fancd2 gene 5' terminus using Crisp...
Flasch, Diane A Macia, Ángela Sánchez, Laura Ljungman, Mats Heras, Sara R García-Pérez, José L Wilson, Thomas E Moran, John V
Published in
Cell
L1 retrotransposon-derived sequences comprise approximately 17% of the human genome. Darwinian selective pressures alter L1 genomic distributions during evolution, confounding the ability to determine initial L1 integration preferences. Here, we generated high-confidence datasets of greater than 88,000 engineered L1 insertions in human cell lines t...
